Loading...

Home
ETF
LENZ

LENZ

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

LENZ News

Lenz Therapeutics Shares Drop Nearly 20% Following Earnings Miss

Mar 27 2026Fool

LENZ THERAPEUTICS INC: BOFA GLOBAL RESEARCH LOWERS PRICE TARGET FROM $35 TO $29

Mar 25 2026moomoo

LENZ Therapeutics Reports Strong Q4 2025 Earnings and Growth Prospects

Mar 24 2026seekingalpha

LENZ Therapeutics Reports Strong Q4 2025 Financials and Product Launch Success

Mar 24 2026Yahoo Finance

Lenz Therapeutics Stock Plummets After Q4 Earnings Miss

Mar 24 2026Fool

LENZ Therapeutics Reports Q4 Earnings Miss

Mar 24 2026seekingalpha

LENZ THERAPEUTICS INC - ESTIMATED Q4 2025 PRODUCT REVENUE NEARS $1.6 MILLION

Mar 24 2026moomoo

LENZ THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS ALONG WITH RECENT CORPORATE DEVELOPMENTS

Mar 24 2026moomoo

LENZ Therapeutics to Announce Q4 Earnings on March 24

Mar 23 2026seekingalpha

FDA Approves Tenpoint's New Eye Drop for Presbyopia

Jan 30 2026Benzinga

FDA Approves Tenpoint's Eye Drops, Competing with LENZ

Jan 30 2026Newsfilter

LENZ Therapeutics Under Investigation, Stock Plummets 26%

Jan 20 2026Globenewswire

LENZ Launches VIZZ Eye Drops, Restoring Near Vision for Up to 10 Hours

Jan 14 2026Newsfilter

LENZ Therapeutics Under Investigation, Stock Plummets 26%

Jan 13 2026Globenewswire

LENZ Therapeutics Faces Investigation After VIZZ Eye Drop Incident, Stock Plummets 26%

Jan 08 2026PRnewswire

LENZ Secures FDA Approval for VIZZ Eye Drops, Reports $1.6M Q4 Revenue

Jan 08 2026NASDAQ.COM